Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population

Toxicology Letters

Volumn 151, Issue 1, 2004, Pages 311-315

  Ada, Ahmet O ^a   Süzen, Sinan H ^a   Iscan, Mumtaz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cytochrome P450 1A1; Genetic polymorphism; Glutathione S transferase M1; Glutathione S transferase T1; Turkish population

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; MUTATION RATE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; CYTOCHROME P-450 CYP1A1; DNA; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TURKEY;

EID: 2942522714     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.075     Document Type: Article

References (18)

1. Abdel-Rahman S.Z., El-zein R.A., Anwar W.A., Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107:1996;229-233
2. Aktas D., Ozen H., Atsu N., Tekin A., Sozen S., Tuncbilek E. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker or invasive bladder cancer? Cancer Genet. Cytogenet. 125:2001;1-4
3. Aynacioglu A.S., Cascorbi I., Mrozikiewicz P.M., Roots I. High frequency of CYP1A1 mutations in a Turkish population. Arch. Toxicol. 72:1998;215-218
4. Bell D.A., Taylor J.A., Paulson D.F., Robenson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of carcinogen-metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164
5. Cascorbi I., Brockmöller J., Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56:1996;4965-4969
6. Chenevix-Trench G., Young J., Coggan M., Board P. Glutathione S-transferase Ml and Tl polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 16:1995;1655-1657
7. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H.M., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stiicker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10:2001;1239-1248
8. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 14:1993;1479-1481
9. Iscan, M.Y., Abu-Hijleh, A.A., Topsoy, S., Bozcaarmutlu, A., Erguney, P., Oguztuzun, S., Bulbul, D., Guray, T., Iscan, M., 2000. Glutathione S-transferase theta (GST T) polymorphism and its toxicological implications. In: The Fourth Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Antalya, Turkey, 12-16 April, Final Programme and Abstracts, p. 23.
10. Mannervik B., Awasthi Y.C., Board P.O., Hayes J.D., Di Ilio C., Ketterer B., Litowski I., Morgenstern R., Muramatsu M., Pearson W.R., Pickett C.B., Salo K., Widerstem M., Wolf C.R. Nomenclature for human glutathione transferase. Biochem. J. 282:1992;305-308
11. Mrozikiewicz P.M., Cascorbi I., Brockmoller J., Roots I. CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping. Pharmacogenetics. 7:1997;303-307
12. Nebert D.W., McKinnon R.A., Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk and toxicity of cancer. DNA Cell Biol. 15:1996;273-280
13. Oke B., Akbas F., Aydin M., Berkkan H. GSTT1 null genotype frequency in a Turkish population. Arch. Toxicol. 72:1998;454-455
14. Peter H., Deutschmann S., Reichel C., Hallier E. Metabolism of methyl chloride by human erythrocytes. Arch. Toxicol. 63:1989;351-355
15. Pinarbasi H., Silig Y., Seyfikli Z., Celik V.K., Pinarbasi E. Genetic polymorphism of GSTM1 in Turkish lung cancer patients. Toxicol. Lett. 123(Suppl. 1):2001;115
16. To-Figueras J., Gene M., Gomez-Catalan J., Galan M.C., Fuentes M., Ramon J.M., Rodamilans M., Huguet E., Corbella J. Glutathione S-transferase M1(GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis. 18:1997;1529-1533
17. Toruner G.A., Akyerli C., Ucar A., Aki T., Atsu N., Ozen H., Tez M., Cetinkaya M., Ozcelik T. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch. Toxicol. 75:2001;459-464
18. Zhong S., Wylie A.H., Barnes D., Wolf C.R., Spun N.K. Relationship between GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 14:1993;1821-1824